Skip to main content
Fig. 6 | BMC Medicine

Fig. 6

From: Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

Fig. 6

Antibody profiles among SARS-CoV-2-infected patients. Differential expression levels of IgG against SARS-CoV-2 spike and nucleocapsid proteins in symptomatic and asymptomatic persons (A) and differential expression levels of IgG against SARS-CoV-2 spike and nucleocapsid proteins in asymptomatic cases (B). The kinetics of IgG in symptomatic and asymptomatic individuals (C) in response to SARS-CoV-2. Data represents the median quantity of antibody quantities per participant category obtained by extracting the medians across the time points per patient and 25th and 75th percentiles

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us